Update: Music trust Hipgnosis Songs delays IPO for second time

To allow for completion of due diligence

Mike Sheen
clock • 2 min read

The Hipgnosis Songs fund, a specialist investment company investing in songs and musical intellectual property rights, has delayed its plans for a £200m initial public offering for a second time, now expected on the 12 September.

The trust was scheduled to be listed on the LSE Main Market on 10 July, but this had been postponed until 1 August to "enable an additional cornerstone investor to finalise due diligence". In an update, the board said the listing had been postponed further as "potential additional cornerstone investors continue to undertake due diligence on the company".  Hipgnosis Songs fund will invest in songs and musical intellectual property rights which involves acquiring songs and enabling investors to benefit from the royalties and related income. Barry McGuigan-backed boxing EIS fund launc...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot